Beställningsvara. Skickas inom 7-10 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.
Osteoporosis, a growing epidemic among women in North America, Europe, and Japan, is a painful, costly disease that has presented a treatment challenge to healthcare professionals. Until recently, therapies have focused on agents that slow bone resorption, and have had only limited success at increasing bone mass.
Osteoporoses: Their Nature and Therapeutic Targets. Osteoporosis - Mechanisms and Models. PTH: Skeletal Effects in the Ovariectomized Rat Model for Postmenopausal Bone Loss. Parathyroid Hormone: The Clinical Experience and Prospects. Adenylyl Cyclase-Activating Anabolic Agents: Parathyroid Hormone and Prostaglandins E. Bone Formation May Be Uncoupled from Resorption, as Demonstrated by a New Class of hPTHrP-(1-34) Analogues in Both Rapid and Slow Turnover Models of Osteopenia. Commercial Exploitation of Parathyroid Hormone Therapy for the Treatment of Postmenopausal Osteoporosis. The Insulin-Like Growth Factors: Potential Anabolic Agents for the Skeleton. Osteogenic Actions of Fluoride: Its Therapeutic Use for Established Osteoporosis. Index.NTI/Sales Copy
David B. Weiner, William V. Williams, USA) Weiner, David B. (University of Pennsylvania, Philadelphia, Philadelphia,) Williams, William V. (University of Pennsylvania School of Medicine
David B. Weiner, William V. Williams, USA) Weiner, David B. (University of Pennsylvania, Philadelphia, Philadelphia,) Williams, William V. (University of Pennsylvania School of Medicine
Eric Moody, Phil Skolnick, USA) Moody, Eric (Johns Hopkins University, Baltimore, Maryland, USA) Skolnick, Phil (Lilly Corporate Center, Indianapolis, Indiana